The purpose of this clinical trial is to evaluate the safety and effectiveness of an oral medication for treating pain related to diabetic neuropathy. The study will compare the oral medication to a single dose of Pregabalin as well as a placebo. Participants will go through three phases: an initial screening, a treatment period, and a follow-up. This research is an important step toward developing better treatment options for people living with diabetic neuropathy pain. All treatments, evaluations, and diagnostic procedures are provided at no cost to you or your insurance
The purpose of this study is to evaluate the safety and effectiveness of an investigational oral medication. Participants will be assigned to receive either one of several different doses of the study medication or a placebo. The study includes an initial screening period to determine eligibility, followed by a treatment phase and a follow-up period for continued monitoring. All study-related treatments, evaluations, and diagnostic procedures are provided at no cost to you or your insurance. This research is an important step toward developing improved treatment options for individuals living with generalized myasthenia gravis.
The purpose of this clinical trial is to evaluate the safety and tolerability of an injectable medication for patients with generalized myasthenia gravis. The study will compare the new once a month injectable medication to a matching placebo injection. Participants have an opportunity to participate in a long term extension study during which they will receive active study medication. This research is an important step toward developing better treatment options for people living with generalized myasthenia gravis. All treatments, evaluations, and diagnostic procedures are provided at no cost to you or your insurance.
The purpose of this clinical trial is to evaluate the safety and efficacy of an oral medication as a preventative for patients with migraines. The study will compare the new twice daily medication to a matching placebo. This study is seeking individuals with episodic or chronic migraines, including those who have not experienced sufficient relief from previous preventive treatments. All treatments, evaluations, and diagnostic procedures are provided at no cost to you or your insurance.
